Caricamento...
Understanding adverse events of immunotherapy: A mechanistic perspective
The treatment of many cancers has been revolutionized by immune checkpoint blockade (ICB) as a standard-of-care therapeutic. Despite many successes, a large proportion of patients treated with ICB agents experience immune-related adverse events (irAEs) in the form of clinical autoimmunity, ranging f...
Salvato in:
| Pubblicato in: | J Exp Med |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Rockefeller University Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754677/ https://ncbi.nlm.nih.gov/pubmed/33601411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20192179 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|